Welcome : Guest

Athersys, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Athersys, Inc., which is principally a Biotechnology Company. Illustrated with 47 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63785
Price: $2350
Company Type: Public
Pages: 49
Date: November 2016
Market Data Tables: 47

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biotechnology......3
Table 1: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......3
Table 2: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......4
Biotesting (Outsourced)......5
Table 3: Outsourced Biotesting Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Environment, Pharma and Others......5
Biotechnology Drugs......6
Table 4: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......6
Stem Cell Transplantation......7
Table 5: Stem Cell Transplantation Market by Category for American Indian and Alaskan Natives in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......7
Table 6: Stem Cell Transplantation Market by Category for Asians in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......8
Table 7: Stem Cell Transplant Market by Category for Black and African Americans in the US (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......9
Table 8: Stem Cell Transplantation Market by Category for Native Hawalian and Other Pacific Islanders in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......10
Table 9: Stem Cell Transplantation Market by Category for Whites in the US (2015) - Percentage Share Breakdown by Volume for Bone Marrow of Periperal Blood and Cord Blood......11
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)......12
Table 10: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......12
Table 11: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Bone Marrow Failure by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......13
Table 12: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......14
Table 13: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Leukemias by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......15
Table 14: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoma by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......16
Table 15: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoproliferative by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......17
Table 16: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......18
Table 17: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non-Malignant Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......19
Table 18: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Plasma Cell Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......20
Table 19: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Solid Tumors by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......21
Table 20: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Americas (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Chronic Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) and Others......22
Table 21: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Europe (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS), Non-Malignant Disorders and Others......23
Table 22: Number of β-thalassemia Patients for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) by Category in Europe (2015) - Percentage Market Share Breakdown by Volume for Bone Marrow (BM), Mixed Chimerism, Peripheral Blood (PB), Unrelated Cord Blood Transplantation (UCB) and Uterine Natural Killer (UNK)......24
Haematopoietic Stem Cell Transplantation (HSCT)......25
Table 23: Haematopoietic Stem Cell Transplantation (HSCT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union, United States and Rest Of World......25
Human Leukocyte Antigen - Identical Sibling Stem Cells......26
Table 24: Human Leukocyte Antigen (HLA) - Identical Sibling Stem Cell Market by Disease Worldwide (2015) - Percentage Share Breakdown by Value for Graft-Versus-Host Disease, Infection, New Malignancy, Organ Failure, Primary Disease and Others......26
Stem Cells (Autologous)......27
Table 25: Autologous Stem Cell Market by Disease Worldwide (2015) - Percentage Share Breakdown by Value for Infection, New Malignancy, Organ Failure, Primary Disease and Others......27
Neurology Devices......28
Table 26: Neurology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cerebrospinal Fluid Management, Interventional Neuroradiology, Neurostimulation, Neurosurgery, and Neurovascular Catheters......28
Table 27: Neurosurgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 Years, 15-44 Years, 45-64 Years, and 65+ Years......29
Inflammatory Bowel Disease (IBD) Drugs......30
Table 28: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......30
Orthopaedic Devices......31
Table 29: Orthopaedic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dental, Extremities, Hip, Knee, Spine, and Trauma......31
Table 30: Orthopaedic Devices Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dental Implants, Hips, Knees, Spine, Trauma, and Others......32
Table 31: Orthopaedic Procedure Sales by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Hip Procedures, and Knee Procedures......33
Table 32: Orthopedics Market by Category Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Biologics, CMF, Dental Implants, Extremities, Hips, Knees, Spine, Sports Medicine, and Trauma......34
Table 33: Orthopaedic Devices Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Artificial Joints, Splints & Fracture Applications, and Others......35
Table 34: Orthopaedic Procedure Sales by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Hip Procedures, and Knee Procedures......36
Table 35: Orthopaedic Surgery Market by Payor in the US (2015) - Percentage Share Breakdown by Value for Medicaid, Medicare, Private Insurance, and Others* (includes Uninsured)......37
Table 36: Orthopedics Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Joint Reconstruction, Spinal Surgery & Spinal Rehabilitation, Trauma & Fixation, Orthobiologicals, Biomaterials & Growth Factors, and Others......38
Orthopedic Foot and Ankle......39
Table 37: Orthopedic Foot and Ankle Market by Category Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Ankle Fusion, Ankle Replacement, Hindfoot Fusion, and Other Fusion (Rearfoot, Midfoot, Forefoot)......39
Biotechnology......40
Table 38: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......40
Table 39: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Others......41
Table 40: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......42
Outsourced Biotesting......43
Table 41: Market Shares of Leading Outsourced Biotesting Companies Worldwide (2015) - Percentage Share Breakdown by Value for Eurofins Scientific, SGS S.A. and Others......43
Colony-Stimulating Factor (GCSF)......44
Table 42: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Qilu pharmaceutical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., and Others......44
CMF Equipment (Orthopedic)......45
Table 43: Market Shares of Leading Orthopedic CMF Equipment Providers by Volume Sales Worldwide (2014) - Percentage Breakdown for Biomet, Inc., Stryker Corporation, Synthes Holding AG, and Others......45
Orthopedic Biologics Equipment......46
Table 44: Market Shares of Leading Orthopedic Biologics Equipment Manufacturers by Volume Sales Worldwide (2014) - Percentage Breakdown for Bacterin International, Inc., Biomet, Inc., Globus Medical, Inc., Johnson & Johnson, Medtronic, Inc., NuVasive, Inc., Orthofix International N.V., Smith & Nephew Plc, Stryker Corporation, Synthes Holding AG, Zimmer Holdings, Inc., and Others......46
Orthopedic Reconstruction......47
Table 45: Market Shares of Leading Orthopedic Reconstruction Product Manufacturers by Value Sales Worldwide (2014) - Percentage Share Breakdown for Biomet, Inc., DePuy Synthes Companies, Smith & Nephew Plc, Stryker Corporation, Wright Medical Group, Inc., and Zimmer Holdings, Inc.......47
Orthopedic Shoulder Implant Devices......48
Table 46: Market Shares of Leading Orthopedic Shoulder Implant Device Manufacturers by Volume Sales Worldwide (2014) - Percentage Breakdown for Biomet, Inc., DJO Incorporated, Exactech, Inc., Johnson & Johnson, Tornier, Inc., Zimmer Holdings, Inc., and Others......48
Orthopedic Trauma Devices......49
Table 47: Market Shares of Leading Orthopedic Trauma Device Manufacturers by Volume Sales Worldwide (2014) - Percentage Breakdown for Biomet, Inc., Johnson & Johnson, Smith & Nephew Plc, Stryker Corporation, Zimmer Holdings, Inc., and Others......49